ZENA.V - Zenabis Global Inc.

TSXV - TSXV Delayed Price. Currency in CAD
1.6800
+0.1200 (+7.69%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.5600
Open1.6500
Bid1.6500 x 0
Ask1.6800 x 0
Day's Range1.6000 - 1.6900
52 Week Range1.4800 - 6.8500
Volume510,179
Avg. Volume895,791
Market Cap341.552M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateFeb 20, 2019 - Feb 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
  • Zenabis fought short-selling financiers in the cannabis industry, but did it win?
    MarketWatch16 days ago

    Zenabis fought short-selling financiers in the cannabis industry, but did it win?

    Zenabis Global Inc. did the unlikely Tuesday: The cannabis company raised cash without going to a group of hedge funds in Canada that deploy aggressive trading strategies to recycle capital in the pot industry.

  • Cannabis stocks rally with Aleafia leading the charge after a capital raise
    MarketWatch22 days ago

    Cannabis stocks rally with Aleafia leading the charge after a capital raise

    Cannabis stocks rose Thursday, led by Aleafia Health Inc., which rallied after announcing the closure of a $40. 25 million convertible debt offering that will bolster its balance sheet and help grow its business.

  • CNW Group2 months ago

    Zenabis Announces Graduation to the Toronto Stock Exchange

    VANCOUVER , May 24, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has received final approval for the listing of the Company's common shares ("Common Shares") and outstanding listed common share purchase warrants ("Warrants") on the Toronto Stock Exchange (the "TSX"). The Company's Common Shares and Warrants will begin trading on the TSX effective as of market open on May 27, 2019 .

  • CNW Group2 months ago

    Zenabis Announces New Appointment to Board of Directors

    VANCOUVER , May 21, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") today announced the appointment of Natascha Kiernan , an experienced international finance and M&A attorney who has held senior positions at several prominent international law firms, as the newest member of its Board of Directors, effective May 20, 2019 . Ms. Kiernan's experience includes working as Counsel in the London office of Skadden, Arps, Slate, Meagher & Flom LLP and she has represented Fortune 500 companies, financial institutions and international governments in complex corporate finance and M&A transactions totalling more than $100 billion in value and spanning six continents. Ms. Kiernan holds a J.D. from Columbia University School of Law and is qualified to practice law in New York and England & Wales .

  • CNW Group2 months ago

    Zenabis Provides Operational Update for April 2019

    Construction and licensing continue to progress on track at Zenabis Atholville and Zenabis Langley, with annual design capacity forecast to increase to at least 131,300 kg in the third quarter of 2019. Zenabis has consistently grown more than the previous month's harvest weight from October 2018 to April of 2019.

  • CNW Group2 months ago

    Zenabis Announces Increase in Licensed Capacity by More Than 30% and Provides Date for Next Operational Update

    VANCOUVER , May 13, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2A at its Zenabis Atholville facility (an additional 3,200kg of cannabis cultivation capacity) and disclose the date of its next operational update: May 21, 2019 (for the month of April 2019 ). This amendment increases licensed operating space from the existing 136,800 square feet at Zenabis Atholville to 174,900 square feet. "Since the creation of Zenabis in January of 2019, we have more than doubled our licensed cultivation capacity from approximately 6,000 kg to 13,400 kg, and we have an additional 9,800 kg of cultivation capacity at Zenabis Atholville submitted and awaiting licensing approval.

  • Newsfile2 months ago

    Zenabis Building a Cannabis Giant Across Canada -- CFN Media

    Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Zenabis Global Inc. (TSXV: ZENA) and its aggressive cannabis production model. With licensed facilities in British Columbia, New Brunswick, and Nova Scotia, near-term and large-scale expansion plans, and supply agreements in place across the country, Zenabis is aiming to take ...

  • CNW Group3 months ago

    Zenabis Announces Grant of Stock Options

    VANCOUVER , May 2, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") announces that it has granted an aggregate of 3,755,511 incentive stock options (each, an "Option") to certain independent directors, officers, employees and consultants of the Company in accordance with the Company's stock option plan on its annual grant cycle. The grant date of these options is May 1, 2019 . Each Option is exercisable into one common share in the capital of the Company (each, a "Share") at a price of $1.91 per Share, being the closing price of the Shares on the TSX Venture Exchange on April 30, 2019 , for a period of three to five years from the date of grant. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • CNW Group3 months ago

    Zenabis Provides Operational and Corporate Updates and Files Sun Pharm Investments Ltd. Year End Financial Statements on SEDAR

    In addition, the Company has filed the financial statements and MD&A for Sun Pharm Investments Ltd. ("Sun Pharm", representing Zenabis' cannabis business prior to the amalgamation with Bevo Agro Inc.) for the year ended December 31, 2018 on SEDAR. Construction is progressing on track at Zenabis Atholville and Zenabis Langley to increase design capacity to at least 131,300 kg by the end of the third quarter of 2019.

  • CNW Group3 months ago

    Zenabis Partners with Farmako to Supply Mass Produced CBD Isolate in Canada and Medical Cannabis to Germany

    Zenabis Partners with Farmako to Supply Mass Produced CBD Isolate in Canada and Medical Cannabis to Germany

  • CNW Group3 months ago

    Zenabis Expands Recreational Cannabis Product Offerings in Key Domestic Markets

    "We are very excited to announce the rollout of our new recreational products as they represent a tangible milestone in our product expansion strategy, which will contribute to overall revenue growth in 2019," stated Andrew Grieve , Chief Executive Officer of Zenabis. The Company's new pre-roll products, initially launched in stores in mid-April, are currently being carried in its key markets of New Brunswick and Nova Scotia . Following the receipt of its oil license as announced in news on March 18, 2019 , the Company has begun offering cannabis oil products under its recreational Namaste brand. Initially, the Company will be offering cannabis oil products in 30 mL bottles and will offer additional products such as soft gel capsules and sprays starting in May 2019 .

  • CNW Group3 months ago

    Zenabis Conditionally Approved to Graduate to the Toronto Stock Exchange

    VANCOUVER , April 22, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has received conditional approval to graduate its listing from the TSX Venture Exchange (the "TSXV") to the Toronto Stock Exchange (the "TSX"). "Moving to the main board of one of the largest exchanges in the world is a critical milestone for the Company in terms of demonstrating the strength of our business and expanding our investment appeal to a broader and global audience," stated Andrew Grieve , Chief Executive Officer of Zenabis.

  • CNW Group3 months ago

    Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option

    VANCOUVER , April 17, 2019 /CNW/ - Zenabis Global Inc. (ZENA.V) ("Zenabis" or the "Company") announces today that it has closed its previously announced fully-marketed, "best efforts" offering (the "Offering") of 12,777,777 units of the Company (each, a "Unit"), which includes the exercise of the agents' over-allotment option in full, at a price of $2.25 per Unit, for aggregate gross proceeds to the Company of approximately $28.75 million , before deducting commissions and expenses of the Offering. Each Unit consists of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months from today's date.  The Warrants have been approved for listing on the TSX Venture Exchange ("TSXV"), under the symbol "ZENA.WT", and trading of the Warrants on the TSXV is expected to commence on April 22, 2019 .

  • CNW Group3 months ago

    IIROC Trading Resumption - ZENA

    IIROC Trading Resumption - ZENA

  • GlobeNewswire3 months ago

    Zenabis Announces Pricing and Update to Terms of Public Offering

    Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that, further to the Company's press release dated April 10, 2019, its fully-marketed, “best efforts” offering (the "Offering") will be of units of the Company (each, a "Unit") at a price of $2.25 per Unit (the "Offering Price"). Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Common Share at a price of $2.75 for a period of 36 months following the closing date of the Offering.

  • CNW Group3 months ago

    IIROC Trading Halt - ZENA

    IIROC Trading Halt - ZENA

  • GlobeNewswire3 months ago

    Zenabis Files Preliminary Prospectus Supplement for Offering of Common Shares

    Zenabis Global Inc (ZENA.V) (“Zenabis” or the “Company”) announces that it has today filed a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated April 9, 2019 (the “Shelf Prospectus”) in connection with a fully-marketed, “best efforts” offering of its common shares (the “Offering”).  The Supplement was filed with the securities regulatory authorities in each of the provinces of Canada, except Québec. The Offering is expected to raise total gross proceeds of approximately $25.0 million before deducting commissions and estimated expenses of the Offering.  The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.

  • CNW Group3 months ago

    Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

    Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

  • CNW Group4 months ago

    Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors

    VANCOUVER , April 1, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) wishes to announce that Donald Fairholm has resigned from its board of directors. The board of directors has initiated the process of finding a new director to fill the vacancy on the board. Note: Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • CNW Group4 months ago

    Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing

    VANCOUVER , March 27, 2019 /CNW/ - Zenabis Global Inc (ZENA.V) ("Zenabis" or the "Company") is pleased to announce that it has closed its previously announced bought deal private placement of 15,000 unsecured convertible debentures (the "Convertible Debentures") of the Company, at a price of $1,000 per Convertible Debenture (the "Issue Price") for gross proceeds of $15,000,000 (the "Offering"). The Company intends to use the net proceeds of the Offering to fund the cost of conversion of its facilities to cannabis production and for working capital.

  • Market Exclusive4 months ago

    Cannabis Stock News Daily Roundup March 21

    AgraFlora Organics International (CSE: AGRA) (OTCPK: PUFXF) is teaming up with Dixie Brands (CSE: DIXI.U) (OTC: DXBRF) (Frankfurt: 0QV) to the manufacture, sale and distribution of cannabis-infused products within legalized markets in the European Union. According to a research report by Prohibition Partners, the cannabis market in the EU may represent as much as €123 […]The post Cannabis Stock News Daily Roundup March 21 appeared first on Market Exclusive.

  • GlobeNewswire4 months ago

    Drink it Up; Cannabis/Hemp Infused Beverage Distribution Agreements In Full Swing

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the latest distribution agreements for cannabis/hemp infused beverages as companies prepare for legal sales. American Premium Water Corporation (OTC: HIPH) is looking at both avenues, having announced that it has launched an updated e-commerce website for its LALPINA CBD brand. The new website will be at www.lalpinahydrocbd.com and will utilize GreenBox POS’ proprietary blockchain based payment process technology, which will allow for uninterrupted e-commerce sales.

  • CNW Group4 months ago

    Zenabis Enters European Pharmaceutical Cannabis Market

    VANCOUVER , March 21, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (ZENA.V) today announced a significant expansion of its supply opportunity through its entrance into the European pharmaceutical cannabis market. Zenabis has entered into a Letter of Intent ("LOI") towards a definitive supply arrangement with Farmako GmbH ("Farmako"), a research-based pharmaceutical company headquartered in Frankfurt, Germany . Pursuant to the LOI, Farmako has committed to an initial purchase of CBD isolate.